Safety and efficacy of combined ruxolitinib and thalidomide in patients with myelofibrosis: Initial results of a phase II study Meeting Abstract


Authors: Rampal, R. K.; Verstovsek, S.; Devlin, S. M.; Stein, E. M.; Kadia, T. M.; Mauro, M. J.; Pemmaraju, N.; Alvarez, K.; Ard, N.; Goodman, T.; Marek, K.; Bose, P.
Abstract Title: Safety and efficacy of combined ruxolitinib and thalidomide in patients with myelofibrosis: Initial results of a phase II study
Meeting Title: 60th Annual Meeting of the American Society of Hematology (ASH)
Journal Title: Blood
Volume: 132
Issue: Suppl. 1
Meeting Dates: 2018 Dec 1-4
Meeting Location: San Diego, CA
ISSN: 0006-4971
Publisher: American Society of Hematology  
Date Published: 2018-11-29
Language: English
ACCESSION: WOS:000454837601063
PROVIDER: wos
DOI: 10.1182/blood-2018-99-114125
Notes: Meeting Abstract: 354 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Eytan Moshe Stein
    342 Stein
  2. Raajit Kumar Rampal
    338 Rampal
  3. Sean McCarthy Devlin
    601 Devlin
  4. Michael John Mauro
    267 Mauro